BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 9179738)

  • 1. Primary systemic amyloidosis with giant hepatomegaly and a swiftly progressive course.
    Mainenti PP; Petrelli G; Lamanda R; Amalfi G; Castiglione F
    J Clin Gastroenterol; 1997 Apr; 24(3):173-5. PubMed ID: 9179738
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatic amyloidosis presenting with severe intrahepatic cholestasis.
    Goenka MK; Bhasin DK; Vasisth RK; Dhawan S
    J Clin Gastroenterol; 1996 Sep; 23(2):134-6. PubMed ID: 8877643
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Portal hypertension and intrahepatic cholestasis in primary amyloidosis.
    Çağlar E; Özbay G; Kalyon H; Sonsuz A
    Turk J Gastroenterol; 2014 Dec; 25 Suppl 1():258-9. PubMed ID: 25910329
    [No Abstract]   [Full Text] [Related]  

  • 4. Myeloma and severe cholestasis.
    Licht A; Maurer R; Oelz O
    Schweiz Med Wochenschr; 1999 Aug; 129(34):1201-4. PubMed ID: 10486860
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Giant hepatomegaly and portal hypertension in an elderly patient with primary liver amyloidosis: an uncommon clinical occurrence.
    Basile G; Villari D; Nicita-Mauro V
    Eur Rev Med Pharmacol Sci; 2000; 4(1-2):47-50. PubMed ID: 11409189
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Huge hepatomegaly, jaundice and portal hypertension due to amyloidosis of the liver.
    Melkebeke P; Vandepitte J; Hannon R; Fevery J
    Digestion; 1980; 20(5):351-7. PubMed ID: 7390060
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Primary systemic amyloidosis with giant hepatomegaly and portal hypertension: a case report and a review of the literature.
    Serra L; Poppi MC; Criscuolo M; Zandomeneghi R
    Ital J Gastroenterol; 1993 Oct; 25(8):435-8. PubMed ID: 8286779
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatomegaly and cholestasis as primary clinical manifestations of an AL-kappa amyloidosis.
    Mohr A; Miehlke S; Klauck S; Röcken C; Malfertheiner P
    Eur J Gastroenterol Hepatol; 1999 Aug; 11(8):921-5. PubMed ID: 10514129
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Primary amyloidosis presenting as intrahepatic cholestasis.
    Bandyopadhyay SK; Bandyopadhyay R; Dutta A
    Indian J Pathol Microbiol; 2006 Oct; 49(4):557-9. PubMed ID: 17183853
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Severe intrahepatic cholestasis, erythrocytosis and hypoglycemia: unusual presenting features of systemic AL amyloidosis.
    Ferreira S; Baldaia C; Fatela N; Ramalho F; Costa MA; Brito D; Esteves G; Monteiro E
    Scand J Gastroenterol; 2008 Mar; 43(3):375-9. PubMed ID: 18938770
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Magnetic resonance imaging with liver-specific contrast agent in primary amyloidosis and intrahepatic cholestasis.
    Møller JM; Santoni-Rugiu E; Chabanova E; Løgager V; Hansen AB; Thomsen HS
    Acta Radiol; 2007 Mar; 48(2):145-9. PubMed ID: 17354133
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Diagnostic difficulties in hepatic amyloidosis--clinical analysis and autopsy data of 3 cases].
    Dabrowska E; Jabłońska-Kaszewska I; Sworczak K; Sliwińska I
    Pol Arch Med Wewn; 1990 Sep; 84(3):176-81. PubMed ID: 2267176
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A case of prominent hepatic cholestasis developing to hepatic failure in lambda-AL amyloidosis.
    Dohmen K; Nagano M; Iwakiri R; Yamano Y; Kikuchi Y; Mizoguchi M; Iwata Y; Mori Y; Ishibashi H
    Gastroenterol Jpn; 1991 Jun; 26(3):376-81. PubMed ID: 1889693
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Hepatic amyloidosis as cause of severe intrahepatic cholestasis].
    Gavilán JC; Bermúdez FJ; Márquez A; Sánchez-Carrillo JJ; González-Santos P
    An Med Interna; 2003 Jan; 20(1):25-7. PubMed ID: 12666305
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Primary amyloidosis of the gastrointestinal tract and liver--two case reports].
    Halm U; Berr F; Eggers E; Wohlgemuth B; Mössner J
    Z Gastroenterol; 1997 Feb; 35(2):131-7. PubMed ID: 9163226
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Two cases of systemic amyloidosis presenting with abnormalities in liver function tests].
    Park JH; Park CK; Yun YM; Hyun DW; Kim ES; Park SY; Jo CM; Tak WY; Kweon YO; Kim SK; Choi YW
    Korean J Gastroenterol; 2003 Oct; 42(4):341-6. PubMed ID: 14634355
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Primary amyloidosis presenting with cholestasis and hyperkinetic portal hypertension.
    Culafić D; Perisić M; Boricić I; Culafić-Vojinović V; Vukcević M
    J Gastrointestin Liver Dis; 2007 Jun; 16(2):201-4. PubMed ID: 17592572
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Severe recurrent intrahepatic cholestasis in systemic AL amyloidosis without evident liver involvement. Unexplained hepatic toxicity or a case of misdiagnosed liver amyloidosis?
    Paudice N; Farsetti S; Caroti L; Ciuti G; Tempestini A; Perfetto F; Bergesio F
    Amyloid; 2011 Jun; 18 Suppl 1():142-4. PubMed ID: 21838465
    [No Abstract]   [Full Text] [Related]  

  • 19. Different morphologic aspects and clinical features in massive hepatic amyloidosis.
    Melato M; Manconi R; Magris D; Morassi P; Benussi DG; Tiribelli C
    Digestion; 1984; 29(3):138-45. PubMed ID: 6745505
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cholestasis and renal failure in a patient with secondary amyloidosis.
    Unsal C; Paydaş S; Gönlüşen G
    Ren Fail; 2002 Nov; 24(6):863-6. PubMed ID: 12472208
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.